transcriptional regulators (Signal/Tanabe)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nametranscriptional regulators (Signal/Tanabe)
Drug Alias NameIL-6 inhibitors (Signal/Tanabe)NF-kappaB/AP-1 inhibitors (Signal/Tanabe)c-Fos inhibitors (Signal/Tanabe)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsInflammationOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSignal Research Division
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSignal Research DivisionTanabe Seiyaku Co Ltd
Active IndicationsN/A
Inactive IndicationsInflammationOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A